ORAL BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE

被引：17
|
作者：
TAYLOR, WB
BATEMAN, DN
机构：
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 31卷 / 01期
关键词：
D O I：
10.1007/BF00870983
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：41 / 44
页数：4
相关论文
共 50 条
  • [41] Pharmacokinetics of high-dose oral and intravenous dexamethasone
    Tóth, GG
    Kloosterman, C
    Uges, DRA
    Jonkman, MF
    THERAPEUTIC DRUG MONITORING, 1999, 21 (05) : 532 - 535
  • [42] Oral pulsed high-dose dexamethasone for myositis
    M. F. G. van der Meulen
    J. E. Hoogendijk
    J. H. J. Wokke
    M. de Visser
    Journal of Neurology, 2000, 247 : 102 - 105
  • [43] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE VS ALIZAPRIDE - A RANDOMIZED CROSSOVER STUDY
    SENG, KTH
    TIONG, CE
    HIANG, TC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (03) : 282 - 284
  • [44] HIGH-DOSE ORAL ERYTHROMYCIN FOR PREVENTING ENDOCARDITIS
    SHANSON, DC
    MCNABB, WR
    RUBY, K
    LANCET, 1983, 1 (8319): : 299 - 300
  • [45] HIGH-DOSE ORAL MAGNESIUM THERAPY IN GYNECOLOGY
    SOLLNER, B
    PERFUSION, 1994, 7 (09): : 327 - 329
  • [46] PHARMACOKINETIC STUDY OF HIGH-DOSE ORAL MELPHALAN
    CHOI, K
    RATAIN, M
    WILLIAMS, S
    GOLICK, J
    BESHCORNER, J
    FULLEM, L
    BITRAN, J
    CLINICAL RESEARCH, 1987, 35 (06): : A863 - A863
  • [47] HIGH-DOSE ORAL AMOXYCILLIN FOR PREVENTING ENDOCARDITIS
    SHANSON, DC
    ASHFORD, RFU
    SINGH, J
    BRITISH MEDICAL JOURNAL, 1980, 280 (6212): : 446 - 446
  • [48] SUDDEN-DEATH AFTER ACUTE DYSTONIC REACTION TO HIGH-DOSE METOCLOPRAMIDE
    POLLERA, CF
    COGNETTI, F
    NARDI, M
    MAZZA, D
    LANCET, 1984, 2 (8400): : 460 - 461
  • [49] DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE - EFFICACY IN CONTROLLING CISPLATIN INDUCED NAUSEA AND VOMITING
    WILLIAMS, OE
    BRITISH MEDICAL JOURNAL, 1984, 289 (6453): : 1232 - 1232
  • [50] POPULATION ANALYSIS OF THE PHARMACOKINETIC VARIABILITY OF HIGH-DOSE METOCLOPRAMIDE IN CANCER-PATIENTS
    GREVEL, J
    WHITING, B
    KELMAN, AW
    TAYLOR, WB
    BATEMAN, DN
    CLINICAL PHARMACOKINETICS, 1988, 14 (01) : 52 - 63
12345